CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
DEXLIFE aims to identify new biomarkers for predicting the onset of type 2 diabetes and evaluating the effectiveness of lifestyle interventions. The project focuses on creating a diagnostic panel to help high-risk individuals receive tailored preventive measures within a health insurance framework.
Type 2 diabetes (T2DM) is preventable by sustained changes in diet and physical exercise.
Despite this, modern societies are already approaching 10% population prevalence of diabetes, and another 15% with pre-diabetes.
The costs of T2DM are huge, approaching 10% of all health costs.
Prevention of diabetes is a priority for national healthcare agencies and for the health insurance industry.
Investment in prevention and lifestyle programmes requires a solid evidence-base for targeting and custom…
NOVO NORDISK INVEST 4 A/S
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Ireland, Dublin
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Barcelona
Type: Research institute
Activity type: Research Organisations
SME: No
Spain, L'Hospitalet De Llobregat
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
